Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells

Journal of Nephrology

Volumn 24, Issue 2, 2011, Pages 218-224

  Takao, Toshihiro ^a   Horino, Taro ^a   Kagawa, Toru ^a   Matsumoto, Reiko ^a   Shimamura, Yoshiko ^a   Ogata, Koji ^a   Inoue, Kousuke ^a   Taniguchi, Yoshinori ^a   Taguchi, Takafumi ^a   Morita, Tatsuhito ^a   Terada, Yoshio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

8 Hydroxy 2' deoxyguanosine; Angiotensin II type 1 receptor blockers; Human renal proximal tubular epithelial cell; Inhibitory kappa B; N Acetyl beta glucosaminidase; P22phox

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CANDESARTAN; I KAPPA B; N ACETYL BETA GLUCOSAMINIDASE; OLMESARTAN; PROTEIN P22; VALSARTAN;

ARTICLE; CELL DAMAGE; CELL LEVEL; CELL LYSATE; CELL PROTECTION; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PROTEIN LOCALIZATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BETA-N-ACETYL-GALACTOSAMINIDASE; CELLS, CULTURED; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GLUCOSE; HUMANS; I-KAPPA B PROTEINS; KIDNEY TUBULES, PROXIMAL; NADPH OXIDASE; OXIDATIVE STRESS; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION;

EID: 79953683981     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2010.5785     Document Type: Article

References (30)

1. Le Hir M, Dubach UC, Schmidt U. Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry. 1979;63:245-251.
2. Fujita H, Narita T, Morii T, et al. Increased urinary excretion of n-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail. 2002;24:69-75.
3. Matheson A, Willcox MD, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev. 2010;26:150-171.
4. Singh DK, Winocour P, Summerhayes B, Viljoen A, Sivakumar G, Farrington K. Are low erythropoietin and 1,25-dihydroxyvitamin d levels indicative of tubulo-interstitial dysfunction in diabetes without persistent microalbuminuria? Diabetes Res Clin Pract. 2009;85:258-264.
5. Dzau VJ, Paul M, Nakamura N, Pratt RE, Ingelfinger JR. Role of molecular biology in hypertension research. State of the art lecture. Hypertension. 1989;13:731-740.
6. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule: an hypothesis for the intrarenal renin angiotensin system. J Clin Invest. 1990;85:417-423.
7. Wolf G, Neilson EG. Effects of angiotensin II on proximal tubular cells stably transfected with the c-mas oncogene. Am J Physiol. 1992;263:F931-F938.
8. Loghman-Adham M, Rohrwasser A, Helin C, et al. A conditionally immortalized cell line from murine proximal tubule. Kidney Int. 1997;52:229-239.
9. Burns KD, Inagami T, Harris RC. Cloning of a rabbit kidney cortex AT1 angiotensin II receptor that is present in proximal tubule epithelium. Am J Physiol. 1993;264:F645-F654.
10. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM. Gene expression of the renin-angiotensin system in human kidney. J Hypertens. 1998;16:91-102.
11. Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 2000;57:601-606.
12. Zimpelmann J, Kumar D, Levine DZ, et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 2000;58:2320-2330.
13. Li JM, Shah AM. Ros generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S221-S226.
14. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18:2439-2446.
15. Li XC, Zhuo JL. Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens. 2008;17:37-43.
16. Takao T, Horino T, Kagawa T, et al. Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells. Am J Nephrol. 2009;29:102-108.
17. Huang JS, Chuang LY, Guh JY, Huang YJ, Hsu MS. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2007;293:F1072-F1082.
18. Kitamura O, Uemura K, Kitamura H, Sugimoto H, Akaike A, Ono T. Serofendic acid protects from iodinated contrast medium and high glucose probably against superoxide production in llc-pk1 cells. Clin Exp Nephrol. 2009;13:15-24.
19. Wang N, Fan Y, Ni P, et al. High glucose effect on the role of cd146 in human proximal tubular epithelial cells in vitro. J Nephrol. 2008;21:931-940.
20. Ishii N, Ogawa Z, Itoh H, Ikenaga H, Saruta T. Diagnostic significance of urinary enzymes for diabetes mellitus and hypertension. Enzyme Protein. 1994;48:174-182.
21. Catalano C, Winocour PH, Parlongo S, Gibb I, Gillespie S, Alberti KG. Measures of tubular function in normoalbuminuric insulin-dependent diabetic patients and their relationship with sodium lithium countertransport activity. Nephron. 1996;73:613-618.
22. Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Hosseini R. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal. 2007;21:413-417.
23. Singh R, Choubey D, Chen J, Leehey DJ. Inhibition of intracellular angiotensin II formation blocks high glucose effect on mesangial matrix. Regul Pept. 2009;158:103-109.
24. Singh VP, Le B, Bhat VB, Baker KM, Kumar R. High-glucoseinduced regulation of intracellular Ang II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol. 2007;293:H939-H948.
25. Ichihara A, Sakoda M, Kurauchi-Mito A, Kaneshiro Y, Itoh H. Renin, prorenin and the kidney: a new chapter in an old saga. J Nephrol. 2009;22:306-311.
26. Cook JL, Re RN, deHaro DL, Abadie JM, Peters M, Alam J. The trafficking protein gabarap binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor. Circ Res. 2008;102:1539-1547.
27. Cook JL, Zhang Z, Re RN. In vitro evidence for an intracellular site of angiotensin action. Circ Res. 2001;89:1138-1146.
28. Re R. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol. 2007;293:H905-H906.
29. Peters J, Obermuller N, Woyth A, et al. Losartan and angiotensin II inhibit aldosterone production in anephric rats via different actions on the intraadrenal renin-angiotensin system. Endocrinology. 1999;140:675-682.
30. Singh VP, Le B, Khode R, Baker KM, Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes. 2008;57:3297-3306.